Calidi Biotherapeutics, Inc. (CLDI)
R&D Expense Growth
-1.12%
Quarterly · Period ending:
CLDI R&D Expense Growth
Latest reported-1.12%period ending
Latest reported-1.12%period ending
CLDI Quarterly R&D Growth (QoQ) (0.00% → -1.12%)
Latest values, visible window
High-resolution chart · PNG
CLDI r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -1.121% | |
| 9.7116% | |
| -0.1271% | |
| -8.9472% | |
| 6.9278% | |
| 33.6088% | |
| -15.699% | |
| -0.6461% | |
| -20.9989% | |
| -30.6973% | |
| 21.7472% | |
| 2.3292% | |
| 21.167% | |
| 15.8639% | |
| 16.3496% | |
| 31.0647% | |
| -5.1757% | |
| 25.6019% | |
| 0% | |
| 0% | |
| 0% |